Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9289108 | 0.96 | KDM4E (0.63) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL6545140 | 0.95 | KDM4E (0.62) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL1998845 | 0.95 | KDM4E (0.62) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL8945396 | 0.95 | KDM4E (0.62) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL10395020 | 0.90 | POLB (0.56) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL10395019 | 0.90 | POLB (0.56) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL5661958 | 0.89 | KDM4E (0.57) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL4914902 | 0.89 | KDM4E (0.55) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL4243868 | 0.87 | KDM4E (0.60) | KDM4EPOLBTDP1MEN1KMT2A | |
| SCHEMBL5406162 | 0.86 | POLB (0.53) | KDM4EPOLBTDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 481 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025062180-A1 | SYSTEMS, METHODS, AND COMPOSITIONS FOR UPCYCLING POLYESTERS | 9449710 CANADA INC. (CA) | 2025-03-27 | — | — | WO | claimed |
| US-10507174-B2 | Skin care compositions | ROHM AND HAAS COMPANY (US) | 2019-12-17 | — | — | US | claimed |
| CN-1124969-A | Styrenic polymer foam with comonomer content | DOW CHEMICAL CO (US) | 1996-06-19 | — | — | CN | claimed |
| US-5489497-A | COMPRISED OF RESIN, MAGNETITE COATED WITH PHOSPHATE TITANIUM COMPOUND, WAX, CHARGE ADDITIVE, SILICA AND METAL OXIDES; ELECTROSTATIC IMAGING | XEROX CORPORATION (US) | 1996-02-06 | — | — | US | claimed |
| US-5326662-A | Passivated toner compositions and processes thereof | XEROX CORPORATION (US) | 1994-07-05 | — | — | US | claimed |
| US-5278018-A | Magnetic toner compositions containing charge enhancing additive particles | XEROX CORPORATION (US) | 1994-01-11 | — | — | US | claimed |
| US-4937163-A | Imaging member and processes thereof | XEROX CORPORATION (US) | 1990-06-26 | — | — | US | claimed |
| US-4920023-A | TREATING COATED CARRIER PARTICLES WITH METAL SALTS OR METAL SALTS OF FATTY ACIDS, MIXING WITH TONER COMPOSITION | XEROX CORPORATION (US) | 1990-04-24 | — | — | US | claimed |
| US-4737434-A | USING PARTICLES OF TWO DIFFERENT POLYMERS | XEROX CORPORATION (US) | 1988-04-12 | — | — | US | claimed |
| US-4565765-A | Process of developing electrostatic latent images comprised of rotating magnets contained in stationary shell and synthetic carrier | XEROX CORPORATION (US) | 1986-01-21 | — | — | US | claimed |
| EP-0145300-A1 | Electrostatic development apparatus | XEROX CORPORATION (US) | 1985-06-19 | — | — | EP | claimed |
| US-4464452-A | NEGATIVE CHARGE ENHANCER | XEROX CORPORATION (US) | 1984-08-07 | — | — | US | claimed |
| US-4298672-A | ELECTROGRAPHY | XEROX CORPORATION (US) | 1981-11-03 | — | — | US | claimed |
| US-4287284-A | AND A DEVELOPER OF BUTYL METHACRYLATE-STYRENE RESIN OR BUTADIENE-STYRENE RESIN WITH CARBON BLACK, AND A CARRIER OF POLYVINYLIDENE FLUORIDE COATED STEEL | XEROX CORPORATION (US) | 1981-09-01 | — | — | US | claimed |
| EP-0005952-A1 | Electrostatographic toner containing an alkyl pyridinium compound and imaging method | XEROX CORPORATION (US) | 1979-12-12 | — | — | EP | claimed |
| JP-58118655-A | — | — | None | — | — | JP | disclosed |
| US-12458931-B2 | Methods for preparing microcapillary carbon molecular sieve membranes | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-4299898-A | Positively charged toners containing quaternary ammonium salts attached to acrylate polymers | XEROX CORPORATION (US) | 1981-11-10 | — | — | US | disclosed |
| US-4187329-A | Electrophotographic developing process and compositions for use therein | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
| EP-0005334-A1 | Electrophotographic toner composition | XEROX CORPORATION (US) | 1979-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10507174-B2 | Skin care compositions | CUTA, MMS19, SOD1 | KDM4E 3609/4885POLB 156/4885TDP1 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.